159 related articles for article (PubMed ID: 11069438)
1. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
Pace S; Longo A; Toon S; Rolan P; Evans AM
Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
[TBL] [Abstract][Full Text] [Related]
3. Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney.
Evans AM; Mancinelli A; Longo A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1071-6. PubMed ID: 9190838
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
[TBL] [Abstract][Full Text] [Related]
5. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
Mancinelli A; Longo A; Shanahan K; Evans AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1122-8. PubMed ID: 7562478
[TBL] [Abstract][Full Text] [Related]
6. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
8. Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation.
Wagner CC; Rusca A; Kletter K; Tschurlovits M; Pace S; Longo A; Pedrani M; Villa R; Frimonti E; Müller M; Brunner M
Xenobiotica; 2011 Nov; 41(11):988-95. PubMed ID: 21810044
[TBL] [Abstract][Full Text] [Related]
9. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
[TBL] [Abstract][Full Text] [Related]
10. Carnitines increase plasma levels of adenosine and ATP in humans.
Capecchi PL; Laghi Pasini F; Quartarolo E; Di Perri T
Vasc Med; 1997; 2(2):77-81. PubMed ID: 9546959
[TBL] [Abstract][Full Text] [Related]
11. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Marzo A; Corsico N; Cardace G; Morabito E
Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
[TBL] [Abstract][Full Text] [Related]
12. Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs.
Cevese A; Schena F; Cerutti G
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():45-56. PubMed ID: 2031871
[TBL] [Abstract][Full Text] [Related]
13. Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene.
Longo A; Bruno G; Curti S; Mancinelli A; Miotto G
J Chromatogr B Biomed Appl; 1996 Nov; 686(2):129-39. PubMed ID: 8971593
[TBL] [Abstract][Full Text] [Related]
14. Changes in the levels of l-carnitine, acetyl-l-carnitine and propionyl-l-carnitine are involved in perfluorooctanoic acid induced developmental cardiotoxicity in chicken embryo.
Jiang Q; Wang C; Xue C; Xue L; Wang M; Li C; Deng Z; Wang Q
Environ Toxicol Pharmacol; 2016 Dec; 48():116-124. PubMed ID: 27771504
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
16. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH
Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006
[TBL] [Abstract][Full Text] [Related]
17. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium.
Cunningham VJ; Rosen SD; Boyd H; Osman S; Davenport RJ; Gunn RN; Pike VW; Camici PG
J Pharmacol Exp Ther; 1996 Apr; 277(1):511-7. PubMed ID: 8613961
[TBL] [Abstract][Full Text] [Related]
18. Serum and urine levels of levocarnitine family components in genetically diabetic rats.
Morabito E; Corsico N; Marzo A; Arrigoni Martelli E
Arzneimittelforschung; 1994 Aug; 44(8):965-8. PubMed ID: 7945543
[TBL] [Abstract][Full Text] [Related]
19. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
